Ingredion Incorporated Reports Third Quarter 2026 Results
Ingredion Incorporated (INGR) reported Q3 2026 results with net sales volume growth in T&HS but a 19% decrease in operating income. Diluted EPS was $2.23 (reported) and $2.28 (adjusted), down from $2.61 and $2.75 in Q3 2025. The company lowered full-year EPS guidance due to higher input costs and softer demand. CEO Jim Zallie cited Argo's slower recovery and manufacturing cost pressures as key challenges.
How this was made
The 30-second read
Why it matters
The earnings miss and lowered guidance are likely to trigger a sell‑off, but long‑term growth platforms and the Tate & Lyle deal may provide upside.
Market read
First‑report earnings with guidance downgrade for a mid‑cap ingredient company; relevant for traders in consumer‑staples and specialty chemicals.
What to watch
Potential upside from the pending Tate & Lyle acquisition and continued clean‑label demand.
Background
Ingredion reported its Q3 2026 earnings, noting slower recovery at its Argo plant, higher input costs, and a sale of its Pakistan business.
Ticker impact
Q3 2026 results posted with EPS down 19% YoY and full-year EPS guidance lowered.
likely pressure as the market prices in weaker earnings and lower outlook
Both reported EPS and guidance are new, material numbers for a mid‑cap issuer.
Market effects
Ingredient solutions sector may see broader pressure as peers face similar input‑cost challenges.
North American food‑ingredient manufacturers could see margin compression.
Limited to companies with exposure to clean‑label trends and commodity cost inflation.
Counterpoint
If cost‑saving initiatives succeed, the stock could rebound despite the guidance cut.
Key entities
- companyIngredion Incorporated
Global provider of ingredient solutions, ticker INGR.



